2023 In Review & 2024 Strategic Plan

Infographic with title: 2023 In Review and ANA logo Under the "Represent" column are graphics for the following: Formed Patient and Family Advisory Board, Hosted Scientific Symposium, Initiated Professional Outreach Under the "Serve" column, there are graphics for the following: Expanded webinar series, 120 questions, 15 countries, More than 5500 website visits, Launched Research survey Under the "Support" column, there are graphics for the following: Joined Global Genes rare disease organization, Published scientific Overview of the 2021 ANA Symposium, Formalized Collaborative relationships with vision for tomorrow and International WAGR Syndrome Association

Thank you to all who supported and donated to ANA in 2023. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2024.

The infographics below provide a snapshot of the accomplishments in 2023 and highlight some goals set for 2024.

ANA Participation in the 6th European Aniridia Conference

Jim Lauderdale, Kelly Trout, Shari Krantz, and Peter Netland stand with a sign regarding the 6th European Aniridia Conference between them

Part of ANA’s vision is to coordinate and synergize its activities and efforts with Aniridia Europe and other international organizations to provide more effective support and affiliations for the global aniridia community. In pursuit of that vision, representatives from ANA were honored to be invited and to participate in the 6th European Aniridia Conference, which was hosted by the Asociación Española de Aniridia in San Juan de Alicante, Spain in June of 2022.

Logo - Outline of an eye, with ANA in the middle and Aniridia North America underneath

Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525

Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.

EIN: 86-2917141

Resize text-+=